Brandes Investment Partners LP Grows Position in Sotera Health (NASDAQ:SHC)

Brandes Investment Partners LP raised its holdings in shares of Sotera Health (NASDAQ:SHC) by 10.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 71,558 shares of the company’s stock after purchasing an additional 7,051 shares during the quarter. Brandes Investment Partners LP’s holdings in Sotera Health were worth $979,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Geode Capital Management LLC boosted its stake in Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after buying an additional 447,186 shares during the period. Maven Securities LTD acquired a new stake in shares of Sotera Health during the third quarter worth about $1,670,000. Cerity Partners LLC acquired a new stake in shares of Sotera Health during the third quarter worth about $1,489,000. Neo Ivy Capital Management acquired a new stake in shares of Sotera Health during the third quarter worth about $720,000. Finally, Barclays PLC lifted its position in shares of Sotera Health by 169.8% during the third quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after purchasing an additional 298,085 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

SHC has been the topic of several research reports. Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research report on Friday, February 28th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $15.92.

Sotera Health Stock Up 2.0 %

Shares of NASDAQ:SHC opened at $11.59 on Friday. The firm’s 50 day moving average price is $13.07 and its 200 day moving average price is $14.26. The stock has a market cap of $3.29 billion, a price-to-earnings ratio of 46.36 and a beta of 1.92. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.